U.S. bolsters drug-factory inspections in India

09/24/2013 | Business Standard (India)

The U.S. FDA is stepping up inspections of drug-industry facilities in India and their compliance with manufacturing standards. The agency is training and enrolling more drugs investigators in the second-biggest supplier of finished dose treatments to the U.S. "Having these additional inspectors in-country will assist the agency in meeting our legislative mandates," U.S. FDA spokesman Christopher C. Kelly said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC